INTERVIEW: Poland's 'innovation-led economy' will offer rich pickings for investors
This article was originally published in Clinica
Poland’s first life sciences-dedicated venture capital fund was launched last week, with $42m in the coffers to invest in early and mid-stage companies. The Joint Polish Investment Fund (JPIF) is led by a team of four partners with track records in the European venture capital and life sciences sectors. Tina Tan speaks to Kreske Nickelsen, one of the partners at JPIF, to find out more about the fund
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.